These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 26232096)
1. The diabetes gene Zfp69 modulates hepatic insulin sensitivity in mice. Chung B; Stadion M; Schulz N; Jain D; Scherneck S; Joost HG; Schürmann A Diabetologia; 2015 Oct; 58(10):2403-13. PubMed ID: 26232096 [TBL] [Abstract][Full Text] [Related]
2. Positional cloning of zinc finger domain transcription factor Zfp69, a candidate gene for obesity-associated diabetes contributed by mouse locus Nidd/SJL. Scherneck S; Nestler M; Vogel H; Blüher M; Block MD; Berriel Diaz M; Herzig S; Schulz N; Teichert M; Tischer S; Al-Hasani H; Kluge R; Schürmann A; Joost HG PLoS Genet; 2009 Jul; 5(7):e1000541. PubMed ID: 19578398 [TBL] [Abstract][Full Text] [Related]
3. The genetic basis of obesity and type 2 diabetes: lessons from the new zealand obese mouse, a polygenic model of the metabolic syndrome. Joost HG Results Probl Cell Differ; 2010; 52():1-11. PubMed ID: 20865367 [TBL] [Abstract][Full Text] [Related]
4. Loss of function of Ifi202b by a microdeletion on chromosome 1 of C57BL/6J mice suppresses 11β-hydroxysteroid dehydrogenase type 1 expression and development of obesity. Vogel H; Scherneck S; Kanzleiter T; Benz V; Kluge R; Stadion M; Kryvych S; Blüher M; Klöting N; Joost HG; Schürmann A Hum Mol Genet; 2012 Sep; 21(17):3845-57. PubMed ID: 22692684 [TBL] [Abstract][Full Text] [Related]
5. Atf6α-null mice are glucose intolerant due to pancreatic β-cell failure on a high-fat diet but partially resistant to diet-induced insulin resistance. Usui M; Yamaguchi S; Tanji Y; Tominaga R; Ishigaki Y; Fukumoto M; Katagiri H; Mori K; Oka Y; Ishihara H Metabolism; 2012 Aug; 61(8):1118-28. PubMed ID: 22386934 [TBL] [Abstract][Full Text] [Related]
6. Mouse KLF11 regulates hepatic lipid metabolism. Zhang H; Chen Q; Yang M; Zhu B; Cui Y; Xue Y; Gong N; Cui A; Wang M; Shen L; Zhang S; Fang F; Chang Y J Hepatol; 2013 Apr; 58(4):763-70. PubMed ID: 23183531 [TBL] [Abstract][Full Text] [Related]
7. Characterisation of the mouse diabetes susceptibilty locus Nidd/SJL: islet cell destruction, interaction with the obesity QTL Nob1, and effect of dietary fat. Plum L; Giesen K; Kluge R; Junger E; Linnartz K; Schürmann A; Becker W; Joost HG Diabetologia; 2002 Jun; 45(6):823-30. PubMed ID: 12107726 [TBL] [Abstract][Full Text] [Related]
8. Pancreatic adipocytes mediate hypersecretion of insulin in diabetes-susceptible mice. Quiclet C; Dittberner N; Gässler A; Stadion M; Gerst F; Helms A; Baumeier C; Schulz TJ; Schürmann A Metabolism; 2019 Aug; 97():9-17. PubMed ID: 31108105 [TBL] [Abstract][Full Text] [Related]
9. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice. Chen Z; Ding L; Yang W; Wang J; Chen L; Chang Y; Geng B; Cui Q; Guan Y; Yang J Diabetes; 2017 May; 66(5):1185-1197. PubMed ID: 28246289 [TBL] [Abstract][Full Text] [Related]
10. Pathophysiology and genetics of obesity and diabetes in the New Zealand obese mouse: a model of the human metabolic syndrome. Kluge R; Scherneck S; Schürmann A; Joost HG Methods Mol Biol; 2012; 933():59-73. PubMed ID: 22893401 [TBL] [Abstract][Full Text] [Related]
11. Role of zinc finger transcription factor zfp69 in body fat storage and diabetes susceptibility of mice. Scherneck S; Vogel H; Nestler M; Kluge R; Schürmann A; Joost HG Results Probl Cell Differ; 2010; 52():57-68. PubMed ID: 20865372 [TBL] [Abstract][Full Text] [Related]
12. Estrogen deficiency aggravates insulin resistance and induces β-cell loss and diabetes in female New Zealand obese mice. Vogel H; Mirhashemi F; Liehl B; Taugner F; Kluth O; Kluge R; Joost HG; Schürmann A Horm Metab Res; 2013 Jun; 45(6):430-5. PubMed ID: 23322514 [TBL] [Abstract][Full Text] [Related]
13. Identification of ABCC8 as a contributory gene to impaired early-phase insulin secretion in NZO mice. Andrikopoulos S; Fam BC; Holdsworth A; Visinoni S; Ruan Z; Stathopoulos M; Thorburn AW; Joannides CN; Cancilla M; Balmer L; Proietto J; Morahan G J Endocrinol; 2016 Jan; 228(1):61-73. PubMed ID: 26493453 [TBL] [Abstract][Full Text] [Related]
14. Ergostatrien-3β-ol from Antrodia camphorata inhibits diabetes and hyperlipidemia in high-fat-diet treated mice via regulation of hepatic related genes, glucose transporter 4, and AMP-activated protein kinase phosphorylation. Kuo YH; Lin CH; Shih CC J Agric Food Chem; 2015 Mar; 63(9):2479-89. PubMed ID: 25693659 [TBL] [Abstract][Full Text] [Related]
15. Dietary treatment of fatty liver: High dietary protein content has an antisteatotic and antiobesogenic effect in mice. Garcia Caraballo SC; Comhair TM; Dejong CHC; Lamers WH; Koehler SE Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1789-1804. PubMed ID: 28457799 [TBL] [Abstract][Full Text] [Related]
16. FABP4-Cre Mediated Expression of Constitutively Active ChREBP Protects Against Obesity, Fatty Liver, and Insulin Resistance. Nuotio-Antar AM; Poungvarin N; Li M; Schupp M; Mohammad M; Gerard S; Zou F; Chan L Endocrinology; 2015 Nov; 156(11):4020-32. PubMed ID: 26248218 [TBL] [Abstract][Full Text] [Related]
17. Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance. Wang XA; Zhang R; Zhang S; Deng S; Jiang D; Zhong J; Yang L; Wang T; Hong S; Guo S; She ZG; Zhang XD; Li H Am J Physiol Endocrinol Metab; 2013 Aug; 305(4):E485-95. PubMed ID: 23695216 [TBL] [Abstract][Full Text] [Related]
18. Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response. Rijkelijkhuizen JM; Doesburg T; Girman CJ; Mari A; Rhodes T; Gastaldelli A; Nijpels G; Dekker JM Metabolism; 2009 Feb; 58(2):196-203. PubMed ID: 19154952 [TBL] [Abstract][Full Text] [Related]
19. FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver. Huang X; Yang C; Luo Y; Jin C; Wang F; McKeehan WL Diabetes; 2007 Oct; 56(10):2501-10. PubMed ID: 17664243 [TBL] [Abstract][Full Text] [Related]